Hospital Serdang

The trials here

What the 11 trials at this site are about, from their registry records.

Conditions

• Heart failure4 trials
• Obesity2 trials
• Atrial fibrillation1 trial
• Chronic kidney disease1 trial
• Coronary artery disease1 trial
• High blood pressure1 trial
• Idiopathic pulmonary fibrosis1 trial
• Lupus (SLE)1 trial
• Pulmonary arterial hypertension1 trial
• Stroke1 trial
• Ulcerative colitis1 trial

Phase

• Phase 34 trials
• Phase 22 trials
• Phase 2/31 trial
• Phase 41 trial

Status

• Active, not recruiting4 trials
• Not yet recruiting2 trials
• Recruiting2 trials
• Terminated2 trials
• Completed1 trial

Lead sponsor

• Novo Nordisk A/S3 trials
• Actelion1 trial
• Amgen1 trial
• Biosensors Europe SA1 trial
• Biotronik SE & Co. KG1 trial
• and 4 more

Running trials

• Not yet recruiting

  A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity

  NCT07861100· Phase 3· Novo Nordisk A/S· Source

  Contact: Novo Nordisk

• Recruiting

  A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  NCT07567001· Phase 3· Novo Nordisk A/S· Source

  Contact: Novo Nordisk

• Recruiting

  LEADERS FREE IV (RCT): BioFreedom™ Ultra vs BioFreedom™ in HBR Patients

  NCT06657326· Biosensors Europe SA· Source

  Contact: Kamaraj a/l Selvaraj, Dr.

• Active, not recruiting

  A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation

  NCT06200207· Phase 3· Novo Nordisk A/S· Source

• Active, not recruiting

  LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

  NCT05321420· Phase 2· PureTech· Source

• Active, not recruiting

  Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension

  NCT04273945· Phase 3· Actelion· Source

• Active, not recruiting

  A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT04033445· Phase 2/3· Janssen Research & Development, LLC· Source

• Recruiting

  Randomised Evaluation of Sodium Dialysate Levels on Vascular Events

  NCT02823821· Phase 4· University of Sydney· Source

  Contact: Grace Balicki

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity2 recruiting
• Chronic kidney disease1 recruiting
• Coronary artery disease1 recruiting
• Heart failure1 recruiting

Closed trials

• Terminated

  Study of Daxdilimab (HZN-7734) in Participants With Active Proliferative Lupus Nephritis (LN)

  NCT05540665· Phase 2· Amgen· Source

• Completed

  Mid-Q Response Study

  NCT04180696· Medtronic Cardiac Rhythm and Heart Failure· Source

• Terminated

  Clinical Benefits of the Closed Loop Stimulation in Sinus Node Disease

  NCT02579889· Biotronik SE & Co. KG· Source